Allergen immunotherapy: exploring areas for further inquiry.
Tam RamseyWanda LaiPeter F SviderHoumehr HojjatJean Anderson EloyAdam J FolbePublished in: International forum of allergy & rhinology (2017)
Despite an immense interest in allergen immunotherapy, this analysis demonstrates that otolaryngologists represented a small proportion of PIs leading associated clinical trials and basic science inquiry. The proportion of trials with industry sponsorship has declined considerably in recent decades. These trends could help direct future resource allocation for allergen immunotherapy.